Avricore Health Inc.
AVCR.V
TSX
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -70.21% | 15.86% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -70.21% | 15.86% | |||
| Cost of Revenue | -89.69% | 6.49% | |||
| Gross Profit | -42.74% | 32.18% | |||
| SG&A Expenses | -20.14% | -16.72% | |||
| Depreciation & Amortization | 14.29% | 40.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -63.38% | -3.63% | |||
| Operating Income | -177.30% | 153.29% | |||
| Income Before Tax | 89.41% | -287.66% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 89.41% | -287.66% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 89.41% | -287.66% | |||
| EBIT | -177.30% | 153.29% | |||
| EBITDA | -114.22% | 544.73% | |||
| EPS Basic | 90.00% | -284.62% | |||
| Normalized Basic EPS | -175.00% | 150.00% | |||
| EPS Diluted | 93.24% | -469.23% | |||
| Normalized Diluted EPS | -175.00% | 150.00% | |||
| Average Basic Shares Outstanding | 0.05% | 0.84% | |||
| Average Diluted Shares Outstanding | 0.05% | 0.84% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||